{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:16:16Z","timestamp":1789611376300,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.ejphar.2010.02.001","type":"journal-article","created":{"date-parts":[[2010,2,17]],"date-time":"2010-02-17T09:17:06Z","timestamp":1266398226000},"page":"101-106","source":"Crossref","is-referenced-by-count":27,"title":["The separate roles of endothelin receptors participate in remodeling of matrix metalloproteinase and connexin 43 of cardiac fibroblasts in maladaptive response to isoproterenol"],"prefix":"10.1016","volume":"634","author":[{"given":"Hong-Jun","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Zai","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2010.02.001_bib1","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1161\/CIRCULATIONAHA.105.573865","article-title":"Matrix metalloproteinases\/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease","volume":"113","author":"Ahmed","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2010.02.001_bib2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/jcp.20034","article-title":"Influence of the extracellular matrix on the regulation of cardiac fibroblast behavior by mechanical stretch","volume":"200","author":"Atance","year":"2004","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.ejphar.2010.02.001_bib3","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/j.transproceed.2007.06.046","article-title":"Down-regulation of matrix metalloproteinase-9 (MMP-9) expression in the myocardium of congestive heart failure patients","volume":"39","author":"Batlle","year":"2007","journal-title":"Transpl. Proc."},{"key":"10.1016\/j.ejphar.2010.02.001_bib4","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1089\/ars.2008.2119","article-title":"Oxidative stress, lens gap junctions, and cataracts","volume":"11","author":"Berthoud","year":"2009","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.ejphar.2010.02.001_bib5","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/aps.2009.104","article-title":"Isoproterenol disperses distribution of NADPH oxidase, MMP-9, and pPKCepsilon in the heart, which are mitigated by endothelin receptor antagonist CPU0213","volume":"30","author":"Cheng","year":"2009","journal-title":"Acta. Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2010.02.001_bib6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/07853890410018925","article-title":"Role of endothelin in fibrosis and anti-fibrotic potential of bosentan","volume":"37","author":"Clozel","year":"2005","journal-title":"Ann. Med."},{"key":"10.1016\/j.ejphar.2010.02.001_bib7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1440-1681.2008.05044.x","article-title":"CPU0213, a non-selective ETA\/ETB receptor antagonist, improves pulmonary arteriolar remodeling of monocrotaline-induced pulmonary hypertension in rats","volume":"36","author":"Cui","year":"2009","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ejphar.2010.02.001_bib8","first-page":"552","article-title":"Endothelin receptor antagonist activity and selective blocking the ETA and ETB of compound 0213","volume":"35","author":"Dai","year":"2004","journal-title":"J. Chinese Pharm. Univ."},{"key":"10.1016\/j.ejphar.2010.02.001_bib9","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1161\/01.HYP.0000198555.51645.f1","article-title":"Leptin regulates cardiomyocyte contractile function through endothelin-1 receptor-NADPH oxidase pathway","volume":"47","author":"Dong","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2010.02.001_bib10","first-page":"306","article-title":"Endothelin receptor antagonist CPU0213 suppresses ventricular fibrillation in l-thyroxin induced cardiomyopathy","volume":"59","author":"Feng","year":"2007","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejphar.2010.02.001_bib11","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1111\/j.1745-7254.2007.00650.x","article-title":"Reversal of isoproterenol-induced downregulation of phospholamban and FKBP12.6 by CPU0213-mediated antagonism of endothelin receptors","volume":"28","author":"Feng","year":"2007","journal-title":"Acta. Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2010.02.001_bib12","doi-asserted-by":"crossref","first-page":"F1635","DOI":"10.1152\/ajprenal.90279.2008","article-title":"Combined knockout of collecting duct endothelin A and B receptors causes hypertension and sodium retention","volume":"295","author":"Ge","year":"2008","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.ejphar.2010.02.001_bib13","doi-asserted-by":"crossref","first-page":"R1898","DOI":"10.1152\/ajpregu.00804.2006","article-title":"Cyclical mechanical stretch modulates expression of collagen I and collagen III by PKC and tyrosine kinase in cardiac fibroblasts","volume":"293","author":"Husse","year":"2007","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ejphar.2010.02.001_bib14","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0022-3565(24)37637-2","article-title":"Receptor-mediated effects of endothelin on the L-type Ca++ current in ventricular cardiomyocytes","volume":"286","author":"Kelso","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2010.02.001_bib15","first-page":"798","article-title":"Distinct lethal arrhythmias susceptibility is associated with sex-related difference in myocardial connexin-43 expression","volume":"29","author":"Knezl","year":"2008","journal-title":"Neuro. Endocrinol. Lett."},{"key":"10.1016\/j.ejphar.2010.02.001_bib16","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1161\/01.RES.0000091364.90121.0C","article-title":"Heterogeneous cell coupling in the heart: an electrophysiological role for fibroblasts","volume":"93","author":"Kohl","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2010.02.001_bib17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jelectrocard.2005.06.096","article-title":"Electrical coupling of fibroblasts and myocytes: relevance for cardiac propagation","volume":"38","author":"Kohl","year":"2005","journal-title":"J. Electrocardiol."},{"key":"10.1016\/j.ejphar.2010.02.001_bib18","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1161\/01.HYP.0000095980.43859.59","article-title":"Endothelin-1 stimulates arterial VCAM-1 expression via NADPH oxidase-derived superoxide in mineralocorticoid hypertension","volume":"42","author":"Li","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2010.02.001_bib19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejphar.2008.06.080","article-title":"Endothelin receptor antagonist CPU0213 and vitamin E reverse downregulation of FKBP12.6 and SERCA2a: a role of hyperphosphorylation of PKCepsilon","volume":"591","author":"Li","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.02.001_bib20","first-page":"281","article-title":"Novel endothelin receptor antagonist CPU0213 suppresses expression of MMPs and TIMPs in hypertrophied myocardium caused by l-thyroxin","volume":"9","author":"Liu","year":"2004","journal-title":"Chin. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2010.02.001_bib21","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jep.2008.05.015","article-title":"Ethanol extracts of Rehmannia complex (Di Huang) containing no Corni fructus improve early diabetic nephropathy by combining suppression on the ET-ROS axis with modulate hypoglycemic effect in rats","volume":"118","author":"Liu","year":"2008","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejphar.2010.02.001_bib22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1517\/13543784.8.1.71","article-title":"The therapeutic potential of PD156707 and related butenolide endothelin antagonists","volume":"8","author":"Maguire","year":"1999","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"10.1016\/j.ejphar.2010.02.001_bib23","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/03008200802151755","article-title":"Biological and pathobiological functions of gelatinase dimers and complexes","volume":"49","author":"Malla","year":"2008","journal-title":"Connect. Tissue Res."},{"key":"10.1016\/j.ejphar.2010.02.001_bib24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00210-007-0134-1","article-title":"Upregulation of leptin pathway correlates with abnormal expression of SERCA2a, phospholamban and the endothelin pathway in heart failure and reversal by CPU86017","volume":"375","author":"Na","year":"2007","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.02.001_bib25","first-page":"H2001","article-title":"Heterogeneous connexin43 expression produces electrophysiological heterogeneities across ventricular wall","volume":"286","author":"Poelzing","year":"2004","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2010.02.001_bib26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1582-4934.2008.00219.x","article-title":"Atrial extracellular matrix remodelling in patients with atrial fibrillation","volume":"12","author":"Polyakova","year":"2008","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2010.02.001_bib27","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/01.fjc.0000211765.52012.aa","article-title":"A novel endothelin receptor antagonist CPU0213 improves diabetic cardiac insufficiency attributed to up-regulation of the expression of FKBP12.6, SERCA2a, and PLB in rats","volume":"47","author":"Qi","year":"2006","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.02.001_bib28","first-page":"1","article-title":"Pharmacological enhancement of cardiac gap junction coupling prevents arrhythmias in canine LQT2 model","volume":"23","author":"Quan","year":"2009","journal-title":"Cell Commun. Adhes."},{"key":"10.1016\/j.ejphar.2010.02.001_bib29","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1161\/01.CIR.0000094397.19932.78","article-title":"Endothelin receptor blockers in cardiovascular disease","volume":"108","author":"Rich","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2010.02.001_bib30","article-title":"Use of vitamins C and E as a prophylactic therapy to prevent postoperative atrial fibrillation","volume":"14","author":"Rodrigo","year":"2009","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ejphar.2010.02.001_bib31","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ahj.2008.01.035","article-title":"Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy","volume":"156","author":"Roldan","year":"2008","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ejphar.2010.02.001_bib32","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.hrthm.2005.10.021","article-title":"Zipes Lecture. Biology and pathobiology of cardiac connexins: from cell to bedside","volume":"3","author":"Saffitz","year":"2006","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ejphar.2010.02.001_bib33","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cardiores.2003.12.017","article-title":"Connexin 43 and ischemic preconditioning","volume":"62","author":"Schulz","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2010.02.001_bib34","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.hrthm.2009.03.012","article-title":"Reactive oxidative metabolites are associated with atrial conduction disturbance in patients with atrial fibrillation","volume":"6","author":"Shimano","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ejphar.2010.02.001_bib35","first-page":"738","article-title":"Dispersion of ventricular mRNA of RyR2 and SERCA2 associated with arrhythmogenesis in rats","volume":"25","author":"Wang","year":"2004","journal-title":"Acta. Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2010.02.001_bib36","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.lfs.2006.06.007","article-title":"Up-regulated inflammatory factors endothelin, NFkappaB, TNFalpha and iNOS involved in exaggerated cardiac arrhythmias in l-thyroxine-induced cardiomyopathy are suppressed by darusentan in rats","volume":"79","author":"Xia","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2010.02.001_bib37","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/FJC.0b013e31817dfc8f","article-title":"The endothelin receptor antagonist CPU0213 is more effective than aminoguanidine to attenuate isoproterenol-induced vascular abnormality by suppressing overexpression of NADPH oxidase, ETA, ETB, and MMP9 in the vasculature","volume":"52","author":"Xu","year":"2008","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.02.001_bib38","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000157628","article-title":"Normalizing NADPH oxidase contributes to attenuating diabetic nephropathy by the dual endothelin receptor antagonist CPU0213 in rats","volume":"29","author":"Xu","year":"2009","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.ejphar.2010.02.001_bib39","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1291\/hypres.25.427","article-title":"Galpha13 induces preproET-1 gene expression via JNK","volume":"25","author":"Yamakaw","year":"2002","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ejphar.2010.02.001_bib40","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/FJC.0b013e31817f36b8","article-title":"Mitogenic effect of arginine vasopressin on adult rat cardiac fibroblast: involvement of PKC-erk1\/2 pathway","volume":"52","author":"Yan-ping","year":"2008","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.02.001_bib41","first-page":"71","article-title":"Heart hypertrophy induced by levothyroxine aggravates ischemic lesions and reperfusion arrhythmias in rats","volume":"18","author":"Yu","year":"1997","journal-title":"Zhong guo yao li xue bao"},{"key":"10.1016\/j.ejphar.2010.02.001_bib42","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ijcard.2008.05.018","article-title":"Downregulated FKBP12.6 expression and upregulated endothelin signaling contribute to elevateddiastolic calcium and arrhythmogenesis in rat cardiomyopathy produced by l-thyroxin","volume":"130","author":"Zhang","year":"2008","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ejphar.2010.02.001_bib43","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1211\/jpp.61.02.0013","article-title":"Strontium fructose 1, 6-diphosphate alleviates early diabetic testopathy by suppressing abnormal testicular matrix metalloproteinase system in streptozocin-treated rats","volume":"61","author":"Zhang","year":"2009","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.02.001_bib44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejheart.2006.04.014","article-title":"Changes in connexin 43, metalloproteinase and tissue inhibitor of metalloproteinase during tachycardia-induced cardiomyopathy in dogs","volume":"9","author":"Zhong","year":"2007","journal-title":"Eur. J. Heart Fail."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299910000841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299910000841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T15:48:09Z","timestamp":1739893689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299910000841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":44,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0014299910000841"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2010.02.001","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}